# Q32 Bio Inc.: filings

QTTB · Nasdaq · CIK 1661998 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qttb.md) · [Financials](/companies/qttb/financials.md) · [Filings](/companies/qttb/filings.md) · [Insiders](/companies/qttb/insiders.md)

## Reports and events: 130 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 237, 8-K 69, 3 39, 10-Q 26, 4/A 15, SC 13G/A 13, 424B3 12, CORRESP 12, UPLOAD 11, EFFECT 10, SCHEDULE 13G 10, 424B5 9, 425 9, SC 13G 9, 10-K 8, DEF 14A 7, DEFA14A 7, S-3 5, S-8 5, SCHEDULE 13D/A 5, SCHEDULE 13G/A 5, SC 13D 4, SC 13D/A 4, SEC STAFF LETTER 4, ARS 3, S-1/A 3, S-4/A 3, 144 2, 3/A 2, CT ORDER 2, D 2, DRS/A 2, DRSLTR 2, POS AM 2, S-1 2, 10-K/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DRS 1, FWP 1, POSASR 1, POS EX 1, PRE 14A 1, S-3ASR 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 13:20 ET | [8-K](/filings/0001193125-26-408435.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408435 |
| 2026-09-14 | 11:15 ET | [8-K](/filings/0001193125-26-389836.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389836 |
| 2026-08-05 | 11:09 ET | [10-Q](/filings/0001193125-26-333831.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333831 |
| 2026-08-05 | 11:02 ET | [8-K](/filings/0001193125-26-333813.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333813 |
| 2026-07-20 | 01:32 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000713.md) | Ownership report, active investor, amended | 0000947871-26-000713 |
| 2026-07-15 | 21:18 ET | [8-K](/filings/0001193125-26-304964.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-304964 |
| 2026-07-13 | 12:39 ET | [8-K](/filings/0001193125-26-301520.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301520 |
| 2026-07-13 | 11:09 ET | [8-K](/filings/0001193125-26-301464.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301464 |
| 2026-06-16 | 20:01 ET | [8-K](/filings/0001193125-26-272562.md) | 5.07 Shareholder vote results | 0001193125-26-272562 |
| 2026-06-01 | 01:10 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000592.md) | Ownership report, active investor, amended | 0000947871-26-000592 |
| 2026-05-28 | 20:28 ET | [SCHEDULE 13D/A](/filings/0001628098-26-000005.md) | Ownership report, active investor, amended | 0001628098-26-000005 |
| 2026-05-27 | 20:01 ET | [8-K](/filings/0001193125-26-241846.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241846 |
| 2026-05-06 | 21:48 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000500.md) | Ownership report, active investor, amended | 0000947871-26-000500 |
| 2026-05-05 | 11:14 ET | [10-Q](/filings/0001193125-26-205021.md) | Quarterly report, period 2026-03-31 | 0001193125-26-205021 |
| 2026-05-05 | 11:04 ET | [8-K](/filings/0001193125-26-205006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205006 |
| 2026-04-30 | 11:02 ET | [DEF 14A](/filings/0001193125-26-193934.md) | Proxy statement, period 2026-06-12 | 0001193125-26-193934 |
| 2026-04-24 | 20:09 ET | [8-K](/filings/0001193125-26-177178.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-177178 |
| 2026-03-27 | 21:15 ET | [8-K](/filings/0001193125-26-129431.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-129431 |
| 2026-03-12 | 21:06 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000245.md) | Ownership report, active investor, amended | 0000947871-26-000245 |
| 2026-03-10 | 11:14 ET | [10-K](/filings/0001193125-26-099339.md) | Annual report, period 2025-12-31 | 0001193125-26-099339 |
| 2026-03-10 | 11:05 ET | [8-K](/filings/0001193125-26-099328.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099328 |
| 2026-02-17 | 21:18 ET | [8-K](/filings/0001193125-26-054711.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-054711 |
| 2025-12-19 | 21:06 ET | [8-K](/filings/0001193125-25-326821.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-326821 |
| 2025-12-01 | 12:14 ET | [8-K](/filings/0001193125-25-303115.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-303115 |
| 2025-11-13 | 12:09 ET | [10-Q](/filings/0001193125-25-278812.md) | Quarterly report, period 2025-09-30 | 0001193125-25-278812 |
| 2025-11-13 | 12:03 ET | [8-K](/filings/0001193125-25-278805.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-278805 |
| 2025-10-21 | 11:05 ET | [8-K](/filings/0001193125-25-244262.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-244262 |
| 2025-08-06 | 11:08 ET | [10-Q](/filings/0000950170-25-103530.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103530 |
| 2025-08-06 | 11:03 ET | [8-K](/filings/0000950170-25-103526.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103526 |
| 2025-06-25 | 12:05 ET | [8-K](/filings/0001193125-25-146179.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-146179 |
| 2025-06-17 | 20:02 ET | [8-K](/filings/0001193125-25-142039.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-142039 |
| 2025-05-23 | 11:00 ET | [8-K](/filings/0001193125-25-125435.md) | 3.01 Delisting notice | 0001193125-25-125435 |
| 2025-05-08 | 11:11 ET | [10-Q](/filings/0000950170-25-066371.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066371 |
| 2025-05-08 | 11:05 ET | [8-K](/filings/0000950170-25-066366.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066366 |
| 2025-04-29 | 11:10 ET | [DEF 14A](/filings/0000950170-25-059558.md) | Proxy statement, period 2025-06-13 | 0000950170-25-059558 |
| 2025-04-25 | 20:02 ET | [8-K](/filings/0001193125-25-096703.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-096703 |
| 2025-03-11 | 11:18 ET | [10-K](/filings/0000950170-25-036823.md) | Annual report, period 2024-12-31 | 0000950170-25-036823 |
| 2025-03-11 | 11:03 ET | [8-K](/filings/0000950170-25-036819.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036819 |
| 2025-03-10 | 11:00 ET | [8-K](/filings/0001193125-25-050372.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-050372 |
| 2025-02-10 | 21:14 ET | [8-K](/filings/0000950170-25-017075.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-017075 |
| 2025-01-13 | 12:30 ET | [8-K](/filings/0001193125-25-004976.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004976 |
| 2024-12-11 | 12:00 ET | [8-K](/filings/0001193125-24-274856.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274856 |
| 2024-11-07 | 12:16 ET | [10-Q](/filings/0000950170-24-122785.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122785 |
| 2024-11-07 | 12:05 ET | [8-K](/filings/0000950170-24-122770.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122770 |
| 2024-08-08 | 11:10 ET | [10-Q](/filings/0000950170-24-093305.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093305 |
| 2024-08-08 | 11:04 ET | [8-K](/filings/0000950170-24-093295.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093295 |
| 2024-07-09 | 11:05 ET | [8-K](/filings/0000950170-24-082307.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-082307 |
| 2024-05-09 | 11:18 ET | [10-Q](/filings/0000950170-24-056273.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056273 |
| 2024-05-09 | 11:06 ET | [8-K](/filings/0000950170-24-056256.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056256 |
| 2024-04-19 | 20:03 ET | [S-1](/filings/0001193125-24-102858.md) | Registration statement | 0001193125-24-102858 |

Page 1 of 3. [Older](/companies/qttb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.